AssureRX Health, a company specialized in pharmacogenetic testing to assist physicians with selecting appropriate antidepressant and antipsychotic drugs for their patients and managing side effects, has appointed three new professionals to their senior management team. According to the company's press release, the new
Monday, September 12, 2011
Biomedical Firm Enhances Management Team for Products Helping Physicians Manage Psychiatric Drugs, Side Effects
Sunday, September 11, 2011
- 4th International Congress on Psychopharmacology, Antalya, Turkey, November 23-27, 2011
- Nevada Psychiatric Association 17th Annual Psychopharmacology Conference, Las Vegas, NV, February 15-19, 2012
Saturday, September 10, 2011
Researchers Find No Strong Increased Risk of Depression Episodes When Pregnant Women Discontinue Antidepressants
Many women who take medication for depression become concerned about the possibility of increasing their risk of a depression episode if they discontinue antidepressants during pregnancy. However, a study published
Tuesday, September 6, 2011
Citing negative patient experiences such as weight gain, sexual dysfunction, and other side effects following substitution of less-expensive generics, members of the Community Behavioral Healthcare Association and other
Drug Topics reported today on research originating at Ohio State University, Columbus, on the treatment compliance of children who were prescribed a six-month drug therapy regimen following depression episodes.
Monday, September 5, 2011
According to a press release, researchers at the 24th European College of Neuropsychopharmacology (ECNP) Congress have presented data that they interpret as demonstrating higher effectiveness of agomelatine (marketed as Valdoxan, a product of the French pharmaceuticals company Servier) than several other antidepressants in
Jimmie L. Foster, National Commander of The American Legion, said in a statement that he finds it alarming that veterans in treatment with the VA (Department of Veterans Affairs) for posttraumatic stress disorder (PTSD) were treated with Risperdal, an antipsychotic drug Foster characterizes as "useless" and not
Sunday, September 4, 2011
Analyzing data from 30,000 adult primary care patients, researchers from several institutions in Israel, including Bar Ilan University and Ben Gurion University of the Negev, found that patient demographic groups
Saturday, September 3, 2011
The American Dental Association has issued a statement to raise awareness that many prescription medications, including antidepressants, can cause dry mouth (xerostomia), which reduces the natural benefits
According to Dr. David Visser, known to viewers of WNDU-TV 16 News (South Bend, Indiana) as The Pet Vet, antidepressants such as Effexor, Cymbalta, Prozac, and Lexapro are the second most frequent medication
Friday, September 2, 2011
Research Finds Doctors Less Likely to Prescribe Antidepressants to African-American and Hispanic Patients
A study of nearly 59,000 visits by adult patients to primary care physicians, published in the journal Psychiatric Services, found that Black and Hispanic patients were less likely than White patients to receive prescriptions for
A drug currently known as BMS-820836, developed by Bristol-Myers Squibb as a potential treatment for patients with whom other antidepressants have been unsuccessful against major depression, has entered
Mother in British Columbia, Canada, Suing GlaxoSmithKline, Alleging Paxil Role in Child's Heart Defect
According to the Times Colonist, a lawsuit against GlaxoSmithKline is in progress in British Columbia, Canada, with the plaintiff arguing that the firm did not adequately disclose the risk of birth defects when the selective
The Scientist reports that reduced levels of stress and anxiety were observed in laboratory mice when researchers added the probiotic bacterium Lactobacillus rhamnosus, citing a study published this week in the
Tuesday, August 30, 2011
The Proceedings of the National Academy of Sciences of the United States of America (PNAS) reports that antiinflammatory medications inhibit antidepressant responses to selective serotonin reuptake inhibitors (SSRIs). SSRIs examined in the study included citalopram and fluoxetine.
Sunday, August 28, 2011
Analysis of Published Research Supports Efficacy of Antidepressant Treatment in Patients With Both Depression and Alcohol Abuse Disorders
The Journal of Clinical Psychiatry has published a meta-analysis of literature on treatment with antidepressant drugs of populations with comorbid clinical depression and alcohol abuse problems, with findings indicating that response to the medications is not hindered by the comorbid disorders.
Testosterone Gel Enhances Sexual Function, Ejaculation Ability in Men Taking SSRI Antidepressants, Researchers Say
In a study published in the journal Sex & Marital Therapy, researchers report that treatment with testosterone gel resulted in significant improvements in sexual functioning and ejaculation ability in men taking selective serotonin reuptake inhibitors (SSRIs) for depression, noting the same degree of improvement regardless of whether the men initially had low testosterone levels due to hypogonadism.
In a column published in the Houston Chronicle, physicians Michael Roizen, M.D., and Mehmet Oz, M.D., caution that patients taking earlier-generation antidepressants, such as MAOIs (monoamine oxidase inhibitors) and tricyclic antidepressants about potential difficulties in maintaining a healthy weight, due to their effects on storage of fat and metabolism.
Reuters reports that research conducted in Finland found that children whose mothers smoked during pregnancy were more likely to eventually be medicated with antidepressants, as well as drugs for anxiety, attention deficit/attention deficit hyperactivity disorder (ADD/ADHD), and other psychiatric conditions.
Wednesday, August 24, 2011
American Medical News, a publication of the American Medical Association, examined the increased trend of physicians prescribing antidepressants to treat "off label" conditions like "fatigue, headaches, and premenstrual problems," citing data from a study published this month in Health Affairs.
Science News reported this week that studies show evidence of lower levels of amyloid-beta proteins, a "brain plaque" associated with Alzheimer's disease, in both mouse and human populations exposed to antidepressant drugs of the selective serotonin reuptake inhibitor class (SSRIs).
According to The Scotsman, researchers at three universities in the United Kingdom--Lincoln, Nottingham, and Warwick--found a link between tricyclic antidepressants and reduced risk for two types of cancer: colorectal cancer and glioma, a form of brain cancer.
FDA Issues "Drug Safety Communication" On Abnormal Heart Rhythms Associated With Celexa at High Doses
In a release to healthcare professionals and patients today, the U.S. Food and Drug Administration (FDA) has warned that citalopram hydrobromide, marketed under the brand Celexa and as generics, should not be used at doses exceeding 40 mg per day, due to a link with altered electrical activity in the heart resulting in potentially fatal abnormal heart rhythms.
Sunday, August 21, 2011
Research reported in the Archives of General Psychiatry in July found that the risk of autism spectrum disorders (ASD) may "modestly increase" in children whose mothers take antidepressants of the selective serotonin reuptake inhibitor (SSRI) class during pregnancy. Risk was highest when exposure occurred during the first trimester.
According to MSNBC, the antipsychotic drug risperidone (marketed by Janssen as Risperdal) is prescribed frequently to treat cases of post-traumatic stress disorder (PTSD) that have not responded well to antidepressant drugs, such as SSRIs (selective serotonin reuptake inhibitors). However, in a new study of veterans with PTSD, the effectiveness of risperidone was found to be no greater than that of placebos.
Results of a new rat study, published in the journal Nature, provides additional evidence for the link between neurogenesis (growth of new brain cells) and the ability to cope with stress. According to a news release from the National Institute of Mental Health, the study adds to a body of research suggesting that neurogenesis may be an important mechanism in the effectiveness of anti-depressant drugs.
Results of a six-year study, published in Stroke: Journal of the American Heart Association, found a 29 percent increase in stroke risk in women with a history of depression. According to the American Heart Association's press release on the study, risk was even higher in women using antidepressant drugs--especially selective serotonin reuptake inhibitors (SSRIs, such as Prozac, Zoloft, and Celexa).